Murine model for mantle cell lymphoma [7]

Leukemia

Volumn 20, Issue 5, 2006, Pages 891-893

  Smith, M R ^a   Joshi, I ^a   Jin, F ^a   Al Saleem, T ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CYCLIN D1; MYC PROTEIN; PRISTANE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER MODEL; CARCINOGENESIS; CELL SUSPENSION; CONTROLLED STUDY; DISEASE ACTIVITY; FLOW CYTOMETRY; GENE EXPRESSION; HISTOLOGY; IMMUNOPHENOTYPING; LETTER; MANTLE CELL LYMPHOMA; MITOGENESIS; MOUSE; MOUSE STRAIN; NONHUMAN; PLASMACYTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RODENT; SPLEEN CELL; SPLENOMEGALY; TRANSGENIC MOUSE;

EID: 33646125208     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404177     Document Type: Letter

References (4)

1. Campo E, Raffeld M, Jaffe ES. Mantle-cell lymphoma. Semin Hematol 1999; 36: 115-127.
2. Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Harris AW, Adams JM. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J 1994; 13: 2124-2130.
3. Anderson PN, Potter M. Induction of plasma cell tumours in BALB-c mice with 2,6,10,14 tetramethylpentadecane (pristane). Nature 1969; 222: 994-995.
4. Potter M, Wax JS. Peritoneal plasmacytogenesis in mice: Comparison of different pristane dose regimens. J Natl Cancer Inst 1983; 1: 391-395.